[
    [
        {
            "time": "",
            "original_text": "健帆生物：目前公司产品已累计销往80个国家，被纳入德国、越南、伊朗、土耳其、泰国、拉脱维亚、波黑7个国家的医保",
            "features": {
                "keywords": [
                    "健帆生物",
                    "产品出口",
                    "国际销售",
                    "医保纳入",
                    "德国",
                    "越南",
                    "伊朗",
                    "土耳其",
                    "泰国",
                    "拉脱维亚",
                    "波黑"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "健帆生物：目前公司产品已累计销往80个国家，被纳入德国、越南、伊朗、土耳其、泰国、拉脱维亚、波黑7个国家的医保",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]